Sacral Neuromodulation as Treatment for Chronic Constipation

Not Applicable

Recruiting

• Conditions: Chronic Constipation
• Interventions: Device: Low Level Laser Therapy

• Registration Number: NCT03819062
• Lead Sponsor: McMaster University

Brief Summary

The objective of this study is to study if low level laser therapy will do more good than harm for patients with severe chronic refractory constipation. It is a proof of concept study without a placebo arm.

Detailed Description

Patients will be offered the therapy if High-Resolution Colonic Manometry has shown that coordination between colon motility and recto-anal activity is abnormal and that autonomic nervous system assessment suggests a dysfunction of communication between the spinal cord autonomic nerves and the colon-rectum-anus. The therapy consists of a 3 week treatment with a total of 8 sessions of low level laser therapy. Effects will be assessed using symptom and quality of life questionnaires and physiological assessments of colon and pelvic floor function, at 4 weeks and 12 weeks.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2019-01-16
• Study First Submitted QC: 2019-01-25
• Study First Posted: 2019-01-28
• Study Start: 2019-09-08
• Status Verified: 2022-04
• Last Update Submitted: 2022-04-04
• Last Update Posted: 2022-04-05
• Primary Completion: 2025-02-01
• Study Completion: 2027-02-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Patients with severe chronic refractory constipation
• Must have undergone high resolution colonic manometry that shows abnormal coordination between colonic motility and ano-rectal function.

Read More

Exclusion Criteria

• Pregnant patients
• Known malignancies in the area of treatment
• Active bleeding in area of treatment
• Active deep vein thrombosis
• When tatoos are present at area of treatment
• Patients that are light sensitive
• Patients who take NSAIDS or steroids.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Refractory Constipation with LLLT	Low Level Laser Therapy	Low level laser therapy (LLLT) will be administered to patients with severe refractory chronic constipation

Primary Outcome Measures

Name	Time	Method
Change in number of bowel movements/week	12 weeks	(significance level P\<0.05 comparing before and after).

Secondary Outcome Measures

Name	Time	Method
Anal spincter pressure	4 weeks	Anorectal manometry, measuring resting anal sphincter pressure in mmHg; comparison before and after treatment.
Change in quality of life assessed by questionnaire PAC-QOL	12 weeks	The PAC-QOL scale is a 28-item self-report instrument designed to evaluate the burden of constipation on patients' everyday functioning and well-being. Each item is rated on a 5-point Likert scale ranging from 0 (not at all) to 4 (extremely). The instrument can be used to generate an overall score, but is also reported to assess 4 specific constipation-related domains including: 1) Worries and concerns (11 items), 2) Physical discomfort (4 items), 3) Psychosocial discomfort (8 items), and 4) Satisfaction (5 items). Each domain score is the mean of the non-missing items for that domain. The total score is the mean of all non-missing items. The range of the domain or total score is 0 (response is 'not at all' for each item) to 4 (response is 'extremely' for each item). A negative change from baseline indicates improvement, a positive change indicates worsening of symptoms. The minimum difference indicating clinically significant improvement is -0.5 (Marquis et al., 2005)
Change in symptoms using the questionnaire PAC-SYM	12 weeks	The PAC-SYM questionnaire is a 12-item questionnaire that evaluates the severity of symptoms of constipation in 3 domains (stool, rectal, and abdominal symptoms) on a 5-point Likert scale ranging from 0 (absent) to 4 (very severe). Each domain score is the mean of the non-missing items for that domain. The total score is the mean of all non-missing items (ie, symptoms). The range of the domain or total score is 0 (response is 'absent' for each item) to 4 (response is 'very severe' for each item). A negative change from baseline indicates improvement, a positive change indicates worsening of symptoms. The minimum important difference indicating clinically significant improvement is minus 0.6 (Saito \& Camilleri, 2018)
Autonomic function assessment	4 weeks	Increase or decrease in parasympathetic reactivity in response to a change in body position from supine to standing expressed as Respiratory Sinus Arrhythmia (ln(ms2)); comparison before and after treatment
Change in anal sphincter pressure due to attempting defecation	4 weeks	Anorectal manometry, measuring change in resting anal sphincter pressure in mmHg; comparison before and after treatment

Trial Locations

Locations (1)

McMaster University; 🇨🇦 Hamilton, Ontario, Canada